Drug-labels.com

Livostin Eye Drops: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
0.5 mg

Patient Medication Information: uses, side effects, how to take - Livostin Eye Drops

ABOUT THIS MEDICATION

What the medication is used for:

Your doctor has prescribed LIVOSTIN* eye drops for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis (red itchy eyes) in adults and children (12 to 65 years old).

What it does:

When LIVOSTIN* is instilled into your eye, it helps reduce the symptoms associated with allergies such as redness and itching of your eyes.

LIVOSTIN* blocks the action of histamine and relieves allergy symptoms. Histamine is a chemical released by the immune system

  • the body’s defence against invading substances - when the body is affected by substances that you are allergic to (allergens).

When it should not be used:

Do not use LIVOSTIN* if you are allergic to it or to any of the non-medicinal ingredients (see What the nonmedicinal ingredients are). If you are not sure, talk to your doctor or pharmacist.

What the medicinal ingredient is:

Levocabastine hydrochloride

What the non-medicinal ingredients are:

Benzalkonium chloride, disodium edetate, disodium phosphate, hypromellose, monosodium phosphate, polysorbate 80, propylene glycol and water for injection.

What dosage forms it comes in:

LIVOSTIN is in the form of eye drops containing 0.5 mg/mL levocabastine. It comes in bottles containing 10 or 15 mL.

WARNINGS AND PRECAUTIONS

DO NOT wear soft contact lenses while being treated with LIVOSTIN*

BEFORE taking LIVOSTIN*, tell your doctor or pharmacist if you:

  • are pregnant or intend to become pregnant while taking this medication;

    • are breast feeding;
    • have known hypersensitivity to this drug or its ingredients;
    • wear soft contact lenses.

WHILE taking LIVOSTIN*:

  • check with your doctor if you are not getting any relief or if any problems develop;
  • report any untoward reactions to your doctor. This is very important, as it will aid in the early detection and prevention of potential complications.
  • if you experience any blurring of vision, do not drive or operate any machinery.

LIVOSTIN usually does not affect alertness or concentration. However, should you feel drowsy, be careful while driving or operating machinery

Not for use in children under 12 years of age.

Your doctor has prescribed this medicine for you. Do not give this medicine to anyone else.

INTERACTIONS WITH THIS MEDICATION

BEFORE taking LIVOSTIN*, tell your doctor or pharmacist if you:

  • are taking any other drug (either prescription or non-prescription)

PROPER USE OF THIS MEDICATION

Usual dose:

The usual dose is 1 drop (15 mcg) of LIVOSTIN* eye drops instilled in each eye, 2 times daily. The dose may be increased to 1 drop 3 to 4 times daily. Always follow your doctor’s instructions.

It is not useful to continue the treatment for more than 3 days if no improvement is seen.

Shake LIVOSTIN* eye drops before each use.

LIVOSTIN* eye drops should be used within one month of the first opening of the bottle.

Overdose:

There has been no experience with overdosage of LIVOSTIN* eye drops.

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

IMPORTANT: PLEASE READ

LIVOSTIN*

Template Date: January 2010 Page 28 of 28

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effect is eye irritation.

Other side effects are headache, drowsiness and fatigue.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / Effect

Talk with your doctor or

pharmacist

Stop taking drug and call your doctor or pharmacist
Only if SevereIn all cases
Common
Uncommon

Allergic

reaction

(rash, hives, swelling of the face,

throat, lips, difficulty swallowing or breathing and

abnormally fast

heartbeats

x

Keratitis, a condition

where the eyes are very painful

watery,

bloodshot, and sensitive to light

x

This is not a complete list of side effects. For any unexpected effects while taking LIVOSTIN*, contact your doctor or pharmacist.

HOW TO STORE IT

LIVOSTIN* eye drops should be stored between 15 and 30 °C.

LIVOSTIN* must be kept out of the reach and sight of children.

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

--------------------------------------------------------------------------

  • Report online at www.healthcanada.gc.ca/medeffect
  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: Canada Vigilance Program Health Canada

      Postal Locator 0701D Ottawa, Ontario

      K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found at: http:// www.novartis.ca or by contacting the sponsor,

Novartis Pharmaceuticals Canada Inc.,

Dorval, QC

H9S 1A9

1-800-363-8883

Last revised: June 17, 2010

*Registered trademark

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02131625

Revision date stated in the text: June 17, 2010

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Livostin Eye Drops

Rx or OTC
Prescription (Rx)?
DIN 02131625
Schedule(s) PRESCRIPTION
Active ingredient(s) Levocabastine (levocabastine hydrochloride) 0.5 MG
Dosage form(s) Suspension, Drops
Route(s) of administration Ophthalmic
Drug class (WHO ATC)
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01G Decongestants and antiallergics
        1. S01GX Other antiallergics
          1. S01GX02 Levocabastine
Company NOVARTIS PHARMACEUTICALS CANADA INC
Current status Cancelled Post Market
Current status date June 27, 2011

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.